TocilizumabV1, Istex, Curation, indexHead, AbsEn.i

Index : AbsEn.i

Les termes de plus forte occurence

834	arthritis
788	patients
713	rheumatoid
473	disease
446	treatment
338	abstract
336	clinical
282	therapy
277	tocilizumab
272	study
270	anti
214	were
211	results
204	inflammatory
190	tnf
186	response
184	these
174	associated
172	factor
170	therapeutic
166	diseases
164	systemic
164	interleukin
162	activity
160	fri
160	efficacy
158	may
158	drugs
158	but
157	cell
152	thu
152	after
148	patient
146	treated
146	also
140	cells
138	review
138	new
138	analysis
136	agents
134	other
132	data
130	receptor
129	role
128	antibody
127	biologic
126	sat
125	inflammation
123	necrosis
123	drug
118	well
115	safety
114	effects
113	rituximab
111	therapies
111	early
109	years
109	levels
109	biological
108	most
108	methotrexate
108	chronic
106	first
106	development
105	than
105	both
104	all
102	high
99	studies
96	tumor
95	joint
95	current
94	remission
93	there
93	juvenile
93	immune
92	factors
91	during
91	biologics
90	risk
90	important
90	however
90	antibodies
89	rheumatic
89	protein
89	case
89	autoimmune
88	significant
88	non
88	increased
87	including
86	year
86	idiopathic
85	serum
84	who
83	severe
82	related
82	modifying
82	cytokines
81	cytokine
80	still
80	effect
79	onset
79	diagnosis
79	active
78	potential
78	induced
77	significantly
77	methods
77	long
77	life
77	human
77	compared
76	only
76	inhibitors
75	different
74	term
74	specific
74	abatacept
73	monoclonal
72	system
71	progression
71	dose
69	expression
69	cases
68	will
68	time
68	rheumatology
67	syndrome
67	novel
66	present
66	bone
65	report
65	observed
64	low
63	trials
63	should
62	target
62	pathogenesis
62	months
62	mechanisms
62	changes
61	infliximab
61	etanercept
60	over
60	had
59	showed
59	recent
59	lupus
59	evaluation
59	conclusion
59	adverse
58	when
58	health
58	dmards
58	control
57	vasculitis
57	large
57	against
56	production
56	improved
56	effective
56	combination
56	assessment
55	practice
55	management
55	inhibitor
55	evidence
55	children
55	association
54	weeks
54	quality
54	phase
54	further
54	controlled
54	cohort
54	administration
54	addition
53	oral
53	improvement
53	alpha
52	trial
52	therefore
52	symptoms
52	positive
52	infections
52	found
52	adalimumab
51	reported
51	rate
51	outcome
51	number
51	literature
51	group
51	available
51	antirheumatic
50	refractory
50	infection
50	impact
50	following
50	developed
50	conventional
50	cancer
49	three
49	recently
49	model
49	level
49	damage
49	could
49	blood
49	age
49	adult
48	without
48	within
48	various
48	several
48	inhibition
48	experience
48	due
48	care
48	article
48	approved
48	abstracts
47	tissue
47	suggest
46	molecular
46	criteria
46	common
46	assessed
46	approach
45	score
45	responses
45	measured
44	reduced
44	receiving
44	objective
44	mediated
44	like
44	joints
44	increase
44	immunosuppressive
44	demonstrated
44	being
43	while
43	randomized
43	radiographic
43	influence
43	future
43	function
43	follow
43	evaluated
42	those
42	respectively
42	population
42	performed
42	outcomes
42	major
42	events
42	blockade
42	activation
42	acr
41	wiley
41	understanding
41	less
41	involved
41	gene
41	especially
41	erythematosus
41	disorders
41	comparison
41	although
40	type
40	treatments
40	total
40	peripheral
40	multiple
40	many
40	groups
40	effectiveness
40	each
40	advances
39	single
39	possible
39	aim
38	under
38	thus
38	targeting
38	serious
38	reactive
38	provide
38	pain
38	known
38	higher
38	evaluate
38	did
38	currently
38	characterized
38	characteristics
38	before
38	acute
38	according
37	synovial
37	rare
37	often
37	investigate
37	index
37	established
37	destruction
37	decreased
37	course
37	complex
37	body
36	whether
36	through
36	strategies
36	registry
36	received
36	profile
36	primary
36	need
36	manifestations
36	despite
36	arteritis
35	since
35	second
35	research
35	rates
35	old
35	japanese
35	include
35	failure
34	tumour
34	side
34	shown
34	sclerosis
34	relationship
34	published
34	play
34	period
34	mtx
34	monotherapy
34	line
34	last
34	findings
34	even
34	conclusions
34	clinically
34	cardiovascular
34	baseline
34	amp
34	agent
33	relevant
33	range
33	models
33	lower
33	key
33	included
33	identified
33	das
33	complications
32	whereas
32	week
32	underlying
32	spondylitis
32	skin
32	reduction
32	process
32	incidence
32	healthy
32	four
32	differences
32	considered
32	classification
32	administered
31	targets
31	regulatory
31	pro
31	pathways
31	measures
31	mean
31	investigated
31	individual
31	improve
31	every
31	duration
31	dmard
31	diagnostic
31	analyses
30	tcz
30	targeted
30	survival
30	real
30	presence
30	options
30	involvement
30	information
30	general
30	disorder
30	corticosteroids
30	ankylosing
29	vitro
29	tuberculosis
29	treating
29	subjects
29	proteins
29	prospective
29	prognosis
29	predict
29	plasma
29	pediatric
29	out
29	mice
29	lead
29	laboratory
29	imaging
29	growth
29	frequently
29	eular
29	critical
29	cause
29	background
29	american
29	action
29	achieved
28	work
28	them
28	systematic
28	secondary
28	result
28	required
28	regarding
28	previous
28	parameters
28	negative
28	markers
28	importance
28	humanized
28	furthermore
28	functional
28	five
28	european
28	described
28	correlated
28	conditions
28	change
28	better
27	via
27	useful
27	small
27	signaling
27	renal
27	monitoring
27	mainly
27	lung
27	intravenous
27	increasing
27	discussed
27	determined
27	contrast
27	blocking
27	binding
27	approaches
27	antigen
26	successful
26	standard
26	sle
26	rapid
26	pulmonary
26	promising
26	moreover
26	molecules
26	meeting
26	mechanism
26	loss
26	least
26	inc
26	inadequate
26	here
26	genetic
26	exposure
26	elevated
25	versus
25	surgery
25	state
25	similar
25	short
25	retrospective
25	respiratory
25	prior
25	option
25	open
25	now
25	knowledge
25	jia
25	focus
25	fever
25	either
25	dependent
25	decrease
25	combined

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/explor/Tocilizumab.storage/TocilizumabV1/Data/Istex/Curation/AbsEn.i.hfd| SxmlCut idx/l | grep ...

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021

	Serveur d'exploration Tocilizumab - Curation (Istex) Index « AbsEn.i » - tête de navigation
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Tocilizumab - Curation (Istex)Index « AbsEn.i » - tête de navigation

Index : AbsEn.i

Les termes de plus forte occurence

Manipulations en shell (Unix/Dilib)

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - tête de navigation